Cargando…

Aspirin in primary prevention: who is the target?

Detalles Bibliográficos
Autores principales:	Gatto, Laura, Romagnoli, Enrico, Prati, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439900/ https://www.ncbi.nlm.nih.gov/pubmed/30948948 http://dx.doi.org/10.1093/eurheartj/suz018

Ejemplares similares

The CLIMA study: assessing the risk of myocardial infarction with a new anatomical score
por: Romagnoli, Enrico, et al.
Publicado: (2019)

Aspirin for primary prevention in the elderly
por: Saad, Marwan, et al.
Publicado: (2019)

Aspirin for primary prevention: Is this the end of the road?
por: Singal, Aayush Kumar, et al.
Publicado: (2019)

Aspirin for Primary Prevention of Cardiovascular Disease
por: Kim, Ji Hye, et al.
Publicado: (2019)

Aspirin for primary prevention of cardiovascular disease
por: Nansseu, Jobert Richie N., et al.
Publicado: (2015)

Aspirin in primary prevention: USPSTF recommendations
por: Aalbers, J
Publicado: (2010)

Molecular targets of aspirin and cancer prevention
por: Alfonso, L, et al.
Publicado: (2014)

Subclinical atherosclerosis: how and when to treat it?
por: Gatto, Laura, et al.
Publicado: (2020)

How should the ticagrelor be used? The point after the TWILIGHT and THEMIS-PCI studies
por: Gatto, Laura, et al.
Publicado: (2020)

Aspirin for primary prevention of cardiovascular disease in diabetes
por: Xing, Ying, et al.
Publicado: (2019)

Aspirin for the primary prevention of cardiovascular disease in the elderly
por: O’Sullivan, Jack W
Publicado: (2019)

Aspirin overutilization for the primary prevention of cardiovascular disease
por: VanWormer, Jeffrey J, et al.
Publicado: (2014)

Aspirin for Primary Prevention: A Challenging Decision
por: Pignone, Michael
Publicado: (2014)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
por: Coccheri, Sergio
Publicado: (2017)

Aspirin in primary prevention of cardiovascular disease in diabetes
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2021)

Use of Aspirin and Statin as primary prevention for cardiovascular diseases
por: Alkhail, Bahaa Aba, et al.
Publicado: (2016)

Primary prevention of myocardial infarction: aspirin is not as useful as it seems
por: Luan, Yi, et al.
Publicado: (2020)

POTENTIAL IMPLICATIONS OF ASPREE ON ASPIRIN PRIMARY PREVENTION GUIDELINES
por: Murray, Anne M
Publicado: (2019)

Aspirin for Primary Prevention of Cardiovascular Diseases: “WALTZ” with the Evidence
por: Dimitriadis, Kyriakos, et al.
Publicado: (2022)

Aspirin for the primary prevention of skin cancer: A meta-analysis
por: ZHU, YUN, et al.
Publicado: (2015)

Aspirin as Primary Prevention of Acute Coronary Heart Disease Events
por: Glasser, Stephen P., et al.
Publicado: (2014)

Aspirin in diabetic patients at primary prevention: insights of the VITAL cohort
por: Caldeira, D., et al.
Publicado: (2023)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
por: Chen, Yinong, et al.
Publicado: (2021)

Aspirin for Prevention of Preeclampsia
por: Atallah, A., et al.
Publicado: (2017)

Aspirin for primary stroke prevention in elderly patients with vascular risk factors
por: Uchiyama, Shinichiro
Publicado: (2017)

Which people should take aspirin for primary prevention of cardiovascular disease?
por: Lozano, Roberto, et al.
Publicado: (2015)

Should Aspirin Be Used for the Primary Prevention of Cardiovascular Disease in the General Population?
por: Huang, Qing-Yu, et al.
Publicado: (2015)

Aspirin Use for Primary Cardiovascular Prevention During the COVID-19 Pandemic
por: Siegel, Arthur J.
Publicado: (2021)

Aspirin and prostate cancer prevention
por: Vidal, Adriana C., et al.
Publicado: (2015)

Aspirin for Prevention of Cardiovascular Disease
por: Mendy, Vincent L., et al.
Publicado: (2017)

New targets for aspirin
por: Bashyam, Hema
Publicado: (2008)

Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis
por: Stegeman, Inge, et al.
Publicado: (2015)

Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach
por: Cofer, Lucas B., et al.
Publicado: (2022)

Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis
por: Tan, Shuai, et al.
Publicado: (2015)

Aspirin for Prevention of Preeclampsia in Lupus Pregnancy
por: Schramm, Amelie M., et al.
Publicado: (2014)

The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis
por: Xie, Wenchao, et al.
Publicado: (2019)

A Systematic Review of Aspirin in Primary Prevention: Is It Time for a New Approach?
por: Brotons, Carlos, et al.
Publicado: (2014)

Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2021)

Aspirin for Primary Stroke Prevention; Evidence for a Differential Effect in Men and Women
por: Gdovinova, Zuzana, et al.
Publicado: (2022)

Accuracy of Electronic Health Record–Documented Aspirin for Primary Prevention in Adult Outpatients
por: Chipalkatti, Naina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_itt5399oolje2dbe0knsvhg3cp